Producing nature's gene-chips: the generation of peptides for display by MHC class I molecules.
暂无分享,去创建一个
[1] N. Shastri,et al. Alloreactive CD8+ T cells can recognize unusual, rare, and unique processed peptide/MHC complexes. , 1996, Journal of immunology.
[2] A. Vitiello,et al. Impaired immunoproteasome assembly and immune responses in PA28-/- mice. , 1999, Science.
[3] A. Goldberg,et al. Interferon-γ Can Stimulate Post-proteasomal Trimming of the N Terminus of an Antigenic Peptide by Inducing Leucine Aminopeptidase* , 1998, The Journal of Biological Chemistry.
[4] M. Feltkamp,et al. Major differences in transporter associated with antigen presentation (TAP)-dependent translocation of MHC class I-presentable peptides and the effect of flanking sequences. , 1995, Journal of immunology.
[5] N. Shastri,et al. Generation of naturally processed peptide/MHC class I complexes is independent of the stability of endogenously synthesized precursors. , 1996, Journal of immunology.
[6] R. Henderson,et al. HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation. , 1992, Science.
[7] L. Eisenlohr,et al. Murine Transporter Associated with Antigen Presentation (TAP) Preferences Influence Class I–restricted T Cell Responses , 1997, The Journal of experimental medicine.
[8] F. Triebel,et al. A non-AUG-defined alternative open reading frame of the intestinal carboxyl esterase mRNA generates an epitope recognized by renal cell carcinoma-reactive tumor-infiltrating lymphocytes in situ. , 1999, Journal of immunology.
[9] A. Agulnik,et al. The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition. , 1997, Immunity.
[10] D. R. Madden,et al. The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation , 1991, Nature.
[11] R. Kridel,et al. Frame of the Human Macrophage Colony-stimulating Factor Gene Is Independently Translated and Codes for an Antigenic Peptide of 14 Amino Acids Recognized by Tumor-infiltrating CD 8 T Lymphocytes , 2001 .
[12] H. Ploegh,et al. Generation, translocation, and presentation of MHC class I-restricted peptides. , 1995, Annual review of biochemistry.
[13] A Sette,et al. The peptide-binding motif for the human transporter associated with antigen processing , 1995, The Journal of experimental medicine.
[14] A. Goldberg,et al. Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[15] H. Rammensee,et al. Uneven tissue distribution of minor histocompatibility proteins versus peptides is caused by MHC expression , 1991, Cell.
[16] R. Henderson,et al. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. , 1992, Science.
[17] Forest M. White,et al. Phosphorylated Peptides Are Naturally Processed and Presented by Major Histocompatibility Complex Class I Molecules in Vivo , 2000, The Journal of experimental medicine.
[18] Hans-Georg Rammensee,et al. MHC Ligands and Peptide Motifs , 1998, Molecular Biology Intelligence Unit.
[19] J. Yewdell,et al. MHC class I-associated peptides produced from endogenous gene products with vastly different efficiencies. , 1997, Journal of immunology.
[20] J. Yewdell,et al. The generation of MHC class I-associated peptides is only partially inhibited by proteasome inhibitors: involvement of nonproteasomal cytosolic proteases in antigen processing? , 1997, Journal of immunology.
[21] S. Rosenberg,et al. The intronic region of an incompletely spliced gp100 gene transcript encodes an epitope recognized by melanoma-reactive tumor-infiltrating lymphocytes. , 1997, Journal of immunology.
[22] Edward J. Collins,et al. Three-dimensional structure of a peptide extending from one end of a class I MHC binding site , 1994, Nature.
[23] Hans-Georg Rammensee,et al. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells , 1990, Nature.
[24] P. Schrier,et al. Interleukin‐2‐induced, melanoma‐specific T cells recognize camel, an unexpected translation product of LAGE‐1 , 1999, International journal of cancer.
[25] N. Shastri,et al. LacZ inducible, antigen/MHC-specific T cell hybrids. , 1994, International immunology.
[26] N. Shastri,et al. The role of MHC class I molecules in the generation of endogenous peptide/MHC complexes. , 1995, Journal of immunology.
[27] A. Diehl,et al. Impaired immune responses and altered peptide repertoire in tapasin-deficient mice , 2000, Nature Immunology.
[28] J. Shabanowitz,et al. An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins , 1996, The Journal of experimental medicine.
[29] C. Watts,et al. Antigen Traffic Pathways in Dendritic Cells , 2000, Traffic.
[30] N. Shastri,et al. Presentation of out-of-frame peptide/MHC class I complexes by a novel translation initiation mechanism. , 1999, Immunity.
[31] P. Kloetzel,et al. Ubiquitin and proteasomes: Antigen processing by the proteasome , 2001, Nature Reviews Molecular Cell Biology.
[32] Jonathan W. Yewdell,et al. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes , 2000, Nature.
[33] U. Koszinowski,et al. Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein , 1991, Cell.
[34] M. Bogyo,et al. A proteolytic system that compensates for loss of proteasome function , 1998, Nature.
[35] R. Henderson,et al. Direct identification of an endogenous peptide recognized by multiple HLA-A2.1-specific cytotoxic T cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[36] Stefan Imreh,et al. Inhibition of antigen processing by the internal repeat region of the EpsteinBarr virus nuclear antigen-1 , 1995, Nature.
[37] A. Varshavsky,et al. The N-end rule: functions, mysteries, uses. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[38] P. Parham,et al. Overlap in the repertoires of peptides bound in vivo by a group of related class I HLA-B allotypes , 1995, Current Biology.
[39] E. Gilboa,et al. A frameshift mutation at the NH2 terminus of the nucleoprotein gene does not affect generation of cytotoxic T lymphocyte epitopes. , 1991, Journal of immunology.
[40] P. Cresswell,et al. How selective is the transporter associated with antigen processing? , 1996, Immunity.
[41] C. Figdor,et al. A Human Minor Histocompatibility Antigen Specific for B Cell Acute Lymphoblastic Leukemia , 1999, The Journal of experimental medicine.
[42] J. Neefjes,et al. The major substrates for TAP in vivo are derived from newly synthesized proteins , 2000, Nature.
[43] T. Elliott,et al. Processing of major histocompatibility class I-restricted antigens in the endoplasmic reticulum , 1995, The Journal of experimental medicine.
[44] J. Shabanowitz,et al. Proteasomes can either generate or destroy MHC class I epitopes: evidence for nonproteasomal epitope generation in the cytosol. , 1998, Journal of immunology.
[45] A. Goldberg,et al. Rate of antigen degradation by the ubiquitin-proteasome pathway influences MHC class I presentation. , 1995, Journal of immunology.
[46] Maria L. Wei,et al. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides , 1992, Nature.
[47] J. Monaco,et al. The genetics of proteasomes and antigen processing. , 1995, Annual review of genetics.
[48] H. Rammensee,et al. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules , 1991, Nature.
[49] N. Shastri,et al. Measurement of ligand-induced activation in single viable T cells using the lacZ reporter gene. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[50] H. Ljunggren,et al. Association of class I major histocompatibility heavy and light chains induced by viral peptides , 1989, Nature.
[51] B. Coupar,et al. Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen , 1988, The Journal of experimental medicine.
[52] J. Yewdell,et al. Trimming of antigenic peptides in an early secretory compartment , 1994, The Journal of experimental medicine.
[53] R. Siliciano,et al. Transporter-independent processing of HIV-1 envelope protein for recognition by CD8+ T cells , 1993, Nature.
[54] K. F. Lindahl,et al. Identification of the rat maternally transmitted minor histocompatibility antigen. , 1997, Journal of immunology.
[55] N. Shastri,et al. Specific proteolytic cleavages limit the diversity of the pool of peptides available to MHC class I molecules in living cells. , 1999, Journal of immunology.
[56] L. Frappier,et al. Human CD8+ T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing. , 1997, Immunity.
[57] C. Farina,et al. Translation of a Retained Intron in Tyrosinase-related Protein (TRP) 2 mRNA Generates a New Cytotoxic T Lymphocyte (CTL)-defined and Shared Human Melanoma Antigen Not Expressed in Normal Cells of the Melanocytic Lineage , 1998, The Journal of experimental medicine.
[58] H. Rammensee,et al. Identification of classical minor histocompatibility antigen as cell-derived peptide , 1990, Nature.
[59] M. Bevan,et al. Introduction of soluble protein into the class I pathway of antigen processing and presentation , 1988, Cell.
[60] L. Kaer,et al. Tapasin: an ER chaperone that controls MHC class I assembly with peptide. , 2001, Trends in immunology.
[61] Hans-Georg Rammensee,et al. Coordinated Dual Cleavages Induced by the Proteasome Regulator PA28 Lead to Dominant MHC Ligands , 1996, Cell.
[62] D. Madden. The three-dimensional structure of peptide-MHC complexes. , 1995, Annual review of immunology.
[63] J. Shabanowitz,et al. Differences in the Expression of Human Class I MHC Alleles and Their Associated Peptides in the Presence of Proteasome Inhibitors1 , 2001, The Journal of Immunology.
[64] N. Shastri,et al. Presentation without Proteolytic Cleavage of Endogenous Precursors in the MHC Class I Antigen Processing Pathway (*) , 1995, The Journal of Biological Chemistry.
[65] H. Yamana,et al. A Gene Encoding Antigenic Peptides of Human Squamous Cell Carcinoma Recognized by Cytotoxic T Lymphocytes , 1998, The Journal of experimental medicine.
[66] J. Yewdell,et al. Mechanisms of exogenous antigen presentation by MHC class I molecules in vitro and in vivo: implications for generating CD8+ T cell responses to infectious agents, tumors, transplants, and vaccines. , 1999, Advances in immunology.
[67] J. Yewdell,et al. Introduction of a Glycosylation Site into a Secreted Protein Provides Evidence for an Alternative Antigen Processing Pathway: Transport of Precursors of Major Histocompatability Complex Class I–Restricted Peptides from the Endoplasmic Reticulum to the Cytosol , 1997, The Journal of experimental medicine.
[68] S. Tonegawa,et al. Altered peptidase and viral-specific T cell response in LMP2 mutant mice. , 1994, Immunity.
[69] A. Goldberg,et al. 26S proteasomes and immunoproteasomes produce mainly N‐extended versions of an antigenic peptide , 2001, The EMBO journal.
[70] P. Coulie,et al. A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[71] K. Rock,et al. Generation of class I MHC-restricted T-T hybridomas. , 1990, Journal of immunology.
[72] Eric O Long,et al. Presentation of a cytosolic antigen by major histocompatibility complex class II molecules requires a long-lived form of the antigen. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[73] S. Tonegawa,et al. TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4−8+ T cells , 1992, Cell.
[74] S. Riddell,et al. Cytomegalovirus selectively blocks antigen processing and presentation of its immediate–early gene product , 1996, Nature.
[75] P. Srivastava,et al. An Endoplasmic Reticulum Protein Implicated in Chaperoning Peptides to Major Histocompatibility of Class I Is an Aminopeptidase* , 2001, The Journal of Biological Chemistry.
[76] K Eichmann,et al. The specificity of proteasomes: impact on MHC class I processing and presentation of antigens , 1999, Immunological reviews.
[77] J. Yewdell,et al. Expression of a membrane protease enhances presentation of endogenous antigens to MHC class I-restricted T lymphocytes , 1992, Cell.
[78] M. Lotze,et al. Identification of T-cell epitopes: rapid isolation of class I-presented peptides from viable cells by mild acid elution. , 1993, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.
[79] T. Braciale,et al. Presentation of viral antigen to class I major histocompatibility complex-restricted cytotoxic T lymphocyte. Recognition of an immunodominant influenza hemagglutinin site by cytotoxic T lymphocyte is independent of the position of the site in the hemagglutinin translation product , 1991, The Journal of experimental medicine.
[80] F. Chisari,et al. Human Transporters Associated with Antigen Processing (Taps) Select Epitope Precursor Peptides for Processing in the Endoplasmic Reticulum and Presentation to T Cells , 1999, The Journal of experimental medicine.
[81] D. Jackson,et al. Coupled Transcription and Translation Within Nuclei of Mammalian Cells , 2001, Science.
[82] W. Green,et al. An alternative translational reading frame encodes an immunodominant retroviral CTL determinant expressed by an immunodeficiency-causing retrovirus. , 1998, Journal of immunology.
[83] A. Goldberg,et al. Degradation of cell proteins and the generation of MHC class I-presented peptides. , 1999, Annual review of immunology.
[84] E. Pamer,et al. The Listeria monocytogenes-secreted p60 Protein Is an N-end Rule Substrate in the Cytosol of Infected Cells , 1997, The Journal of Biological Chemistry.
[85] P. Paz,et al. Discrete proteolytic intermediates in the MHC class I antigen processing pathway and MHC I-dependent peptide trimming in the ER. , 1999, Immunity.
[86] T. Boon,et al. T cell-recognized antigenic peptides derived from the cellular genome are not protein degradation products but can be generated directly by transcription and translation of short subgenic regions. A hypothesis , 2004, Immunogenetics.
[87] Hans-Georg Rammensee,et al. Cellular peptide composition governed by major histocompatibility complex class I molecules , 1990, Nature.
[88] N. Shastri,et al. A rare cryptic translation product is presented by Kb major histocompatibility complex class I molecule to alloreactive T cells , 1995, The Journal of experimental medicine.
[89] S. Rosenberg,et al. Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen , 1996, The Journal of experimental medicine.
[90] W. Baumeister,et al. A giant protease with potential to substitute for some functions of the proteasome. , 1999, Science.
[91] Hans-Georg Rammensee,et al. Two new proteases in the MHC class I processing pathway , 2000, Nature Immunology.
[92] N. Shastri,et al. Endogenous generation and presentation of the ovalbumin peptide/Kb complex to T cells. , 1993, Journal of immunology.
[93] A. Goldberg,et al. Distinct proteolytic processes generate the C and N termini of MHC class I-binding peptides. , 1999, Journal of immunology.
[94] P. Cresswell,et al. The nature of the MHC class I peptide loading complex , 1999, Immunological reviews.
[95] J. Yewdell,et al. Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules? , 1996, Journal of immunology.
[96] S. Rosenberg,et al. A breast and melanoma-shared tumor antigen: T cell responses to antigenic peptides translated from different open reading frames. , 1998, Journal of immunology.
[97] A. Goldberg,et al. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules , 1994, Cell.
[98] T. Elliott,et al. Naturally processed peptides , 1990, Nature.
[99] L. Eisenlohr,et al. Initiation Codon Scanthrough versus Termination Codon Readthrough Demonstrates Strong Potential for Major Histocompatibility Complex Class I–restricted Cryptic Epitope Expression , 1997, The Journal of experimental medicine.
[100] H. Eisen,et al. Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. , 1996, Immunity.
[101] T. Yasuda,et al. Identification of a unique antigen peptide pRL1 on BALB/c RL male 1 leukemia recognized by cytotoxic T lymphocytes and its relation to the Akt oncogene , 1994, The Journal of experimental medicine.
[102] L. Eisenlohr,et al. Ribosomal scanning past the primary initiation codon as a mechanism for expression of CTL epitopes encoded in alternative reading frames , 1996, The Journal of experimental medicine.
[103] E. Pamer,et al. Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes , 1991, Nature.
[104] R. Henderson,et al. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. , 1994, Science.
[105] J. Monaco,et al. Structural and serological similarity of MHC-linked LMP and proteasome (multicatalytic proteinase) complexes , 1991, Nature.
[106] R. Binder,et al. Heat Shock Protein-chaperoned Peptides but Not Free Peptides Introduced into the Cytosol Are Presented Efficiently by Major Histocompatibility Complex I Molecules* , 2001, The Journal of Biological Chemistry.
[107] P. A. Peterson,et al. Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb. , 1994, Science.
[108] J. Pipas,et al. 8 – Cytotoxic T Cell Recognition of the SV40 Tumor Antigen: A Note of Caution , 1988 .
[109] C. Melief,et al. The rat cim effect: TAP allele-dependent changes in a class I MHC anchor motif and evidence against C-terminal trimming of peptides in the ER. , 1996, Immunity.
[110] J. Yewdell,et al. Direct delivery of exogenous MHC class I molecule-binding oligopeptides to the endoplasmic reticulum of viable cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[111] H. Rammensee,et al. Characterization of naturally occurring minor histocompatibility peptides including H-4 and H-Y. , 1990, Science.
[112] T. Elliott,et al. Recognition of out‐of‐frame major histocompatibility complex class I‐restricted epitopes in vivo , 1996, European journal of immunology.
[113] P. Srivastava,et al. Heat shock proteins come of age: primitive functions acquire new roles in an adaptive world. , 1998, Immunity.
[114] P. Paz,et al. Reading within the lines: naturally processed peptides displayed by MHC class I molecules. , 1998, Current opinion in immunology.
[115] K. Rajewsky,et al. MHC class I expression in mice lacking the proteasome subunit LMP-7. , 1994, Science.
[116] P. Chomez,et al. Genes coding for T-cell-defined tum transplantation antigens: point mutations, antigenic peptides, and subgenic expression. , 1989, Cold Spring Harbor symposia on quantitative biology.
[117] N. Bhardwaj,et al. Dendritic cells resurrect antigens from dead cells. , 2001, Trends in immunology.
[118] F. Koning,et al. Isolation of an immunodominant viral peptide that is endogenously bound to the stress protein GP96/GRP94. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[119] S. Nathenson,et al. Isolation of an endogenously processed immunodominant viral peptide from the class I H–2Kb molecule , 1990, Nature.
[120] H. Yonekawa,et al. Maternally transmitted histocompatibility antigen of mice: A hydrophobic peptide of a mitochondrially encoded protein , 1990, Cell.
[121] J. Yewdell,et al. Two Novel Routes of Transporter Associated with Antigen Processing (TAP)-independent Major Histocompatibility Complex Class I Antigen Processing , 1997, The Journal of experimental medicine.
[122] R. Siliciano,et al. An epitope-selective, transporter associated with antigen presentation (TAP)-1/2-independent pathway and a more general TAP-1/2-dependent antigen-processing pathway allow recognition of the HIV-1 envelope glycoprotein by CD8+ CTL. , 1995, Journal of immunology.
[123] L. Kaer,et al. Impaired assembly yet normal trafficking of MHC class I molecules in Tapasin mutant mice. , 2000, Immunity.
[124] N. Shastri,et al. ER aminopeptidases generate a unique pool of peptides for MHC class I molecules , 2001, Nature Immunology.
[125] P. Endert. Genes regulating MHC class I processing of antigen , 1999 .
[126] P M Kloetzel,et al. A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation. , 1996, Immunity.
[127] D. Wiley,et al. T Cell Receptor–MHC Interactions up Close , 2001, Cell.
[128] N. Brouwenstijn,et al. MHC class I molecules can direct proteolytic cleavage of antigenic precursors in the endoplasmic reticulum. , 2001, Immunity.
[129] N. Shastri,et al. Major Histocompatibility Class I Molecules Can Present Cryptic Translation Products to T-cells (*) , 1995, The Journal of Biological Chemistry.
[130] P. Paz,et al. Minors held by majors: the H13 minor histocompatibility locus defined as a peptide/MHC class I complex. , 1997, Immunity.
[131] J. Yewdell,et al. Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. , 1997, Immunity.
[132] Ira Mellman,et al. Dendritic Cells Specialized and Regulated Antigen Processing Machines , 2001, Cell.
[133] G W Butcher,et al. Two different, highly exposed, bulged structures for an unusually long peptide bound to rat MHC class I RT1-Aa. , 2001, Immunity.
[134] F. Brasseur,et al. A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N- acetylglucosaminyltransferase V gene , 1996, The Journal of experimental medicine.